
    
      OBJECTIVES:

      Primary:To assess the treatment response rate (RR) of Endostar in combination with CCRT

      Secondary

        -  The progression-free survival (PFS)

        -  The overall survival(OS).

        -  The failed treatment modality.

        -  The toxicity of this regimen.

      OUTLINE CCRT:Patients receive chemotherapy comprising Docetaxel(65mg/m2,iv gtt duration>1h)
      and Cisplatin(65mg/m2,concurrent hydration) on days 1 and 29 and at least 3 hours after
      chemotherapy undergo concurrent 3D-CRT five days a week for total dose 60-66Gy.

      Endostatin:Patients receive Endostatin 7.5mg/m2 daily by iv gtt up to 7 days consecutively 1
      week before radiotherapy and repeat every 2 weeks.

      Patients are seen in follow-up every 3 months for 2 years and then every 6 months thereafter.
      Physical examination and CT scans of the thorax and upper abdomen are performed routinely.
    
  